These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1828693)

  • 21. Novel phenotype associated with in vivo activated CTL precursors.
    Oughton JA; Kerkvliet NI
    Clin Immunol; 1999 Mar; 90(3):323-33. PubMed ID: 10075861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype.
    Dengler TJ; Pober JS
    J Immunol; 2000 May; 164(10):5146-55. PubMed ID: 10799873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between CD8 dependency and determinant density using peptide-induced, Ld-restricted cytotoxic T lymphocytes.
    Alexander MA; Damico CA; Wieties KM; Hansen TH; Connolly JM
    J Exp Med; 1991 Apr; 173(4):849-58. PubMed ID: 1901079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+CD45RA+CD27- human T cells.
    Baars PA; Ribeiro Do Couto LM; Leusen JH; Hooibrink B; Kuijpers TW; Lens SM; van Lier RA
    J Immunol; 2000 Aug; 165(4):1910-7. PubMed ID: 10925272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Difference between antigen-binding receptor repertoires in effector cytotoxic T lymphocytes and their secondary precursors (memory cells) specific to H-2Kb.
    Brondz BD; Osipova TV; Aptikaeva GE; Kronin VV
    Res Immunol; 1990 Jan; 141(1):43-57. PubMed ID: 1693215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection.
    McFarland HI; Nahill SR; Maciaszek JW; Welsh RM
    J Immunol; 1992 Aug; 149(4):1326-33. PubMed ID: 1500720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rejection of allogeneic tumor is not determined by host responses to MHC class I molecules and is mediated by CD4-CD8+ T lymphocytes that are not lytic for the tumor.
    Cole GA; Ostrand-Rosenberg S
    Cell Immunol; 1991 May; 134(2):480-90. PubMed ID: 1902400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of functional heterogeneity in the CD8 subset with T cells from T cell receptor-transgenic mice.
    Gaugler B; Schmitt-Verhulst AM; Guimezanes A
    Eur J Immunol; 1993 Aug; 23(8):1851-8. PubMed ID: 8344346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-selective cytolysis is executed exclusively by CD45R+ CTL whereas allo-specific cytotoxicity can be executed also by CD45R- CTL.
    Ericsson PO; Hedlund G; Hansson J; Dohlsten M; Sjögren HO
    Cell Immunol; 1990 Mar; 126(1):69-79. PubMed ID: 2137377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.
    Kitagawa S; Iwata H; Sato S; Shimizu J; Hamaoka T; Fujiwara H
    J Exp Med; 1991 Sep; 174(3):571-81. PubMed ID: 1678775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of cytotoxic granules in human memory CD8+ T cell subsets requires cell cycle progression.
    Meng Y; Harlin H; O'Keefe JP; Gajewski TF
    J Immunol; 2006 Aug; 177(3):1981-7. PubMed ID: 16849512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.
    Rosenberg AS; Munitz TI; Maniero TG; Singer A
    J Exp Med; 1991 Jun; 173(6):1463-71. PubMed ID: 1674524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in surface phenotype between cytolytic and non-cytolytic CD4+ T cells. MHC class II-specific cytotoxic T lymphocytes lack Leu 8 antigen and express CD2 in high density.
    Takada S; Koide J; Engleman EG
    J Immunol; 1989 May; 142(9):3038-44. PubMed ID: 2468710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A subpopulation of mouse cytotoxic T lymphocytes recognizes allogeneic H-2 class I antigens in the context of other H-2 class I molecules.
    Kievits F; Ivanyi P
    J Exp Med; 1991 Jul; 174(1):15-9. PubMed ID: 1905337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human CD8+ T lymphocytes can be divided into CD45RA+ and CD45RO+ cells with different requirements for activation and differentiation.
    de Jong R; Brouwer M; Miedema F; van Lier RA
    J Immunol; 1991 Apr; 146(7):2088-94. PubMed ID: 1826015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The degree of CD8 dependence of cytolytic T cell precursors is determined by the nature of the T cell receptor (TCR) and influences negative selection in TCR-transgenic mice.
    Auphan N; Curnow J; Guimezanes A; Langlet C; Malissen B; Mellor A; Schmitt-Verhulst AM
    Eur J Immunol; 1994 Jul; 24(7):1572-7. PubMed ID: 8026519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-10: a novel cytotoxic T cell differentiation factor.
    Chen WF; Zlotnik A
    J Immunol; 1991 Jul; 147(2):528-34. PubMed ID: 1906502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
    De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient-individualized CD8⁺ cytolytic T-cell therapy effectively combats minimal residual leukemia in immunodeficient mice.
    Distler E; Albrecht J; Brunk A; Khan S; Schnürer E; Frey M; Mottok A; Jordán-Garrote AL; Brede C; Beilhack A; Mades A; Tomsitz D; Theobald M; Herr W; Hartwig UF
    Int J Cancer; 2016 Mar; 138(5):1256-68. PubMed ID: 26376181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective reactivity of CD8-independent T lymphocytes to a cytotoxic T lymphocyte-selected H-2Kb mutant altered at position 222 in the alpha 3 domain.
    Shepherd SE; Sun R; Nathenson SG; Sheil JM
    Eur J Immunol; 1992 Mar; 22(3):647-53. PubMed ID: 1547812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.